Iskenderian, A., Liu, N., Deng, Q., Huang, Y., Shen, C., Palmieri, K., . . . Ehmann, D. E. (2018). Myostatin and activin blockade by engineered follistatin results in hypertrophy and improves dystrophic pathology in mdx mouse more than myostatin blockade alone. Skelet Muscle.
शिकागो स्टाइल उद्धरणIskenderian, Andrea, et al. "Myostatin and Activin Blockade By Engineered Follistatin Results in Hypertrophy and Improves Dystrophic Pathology in Mdx Mouse More Than Myostatin Blockade Alone." Skelet Muscle 2018.
एमएलए उद्धरणIskenderian, Andrea, et al. "Myostatin and Activin Blockade By Engineered Follistatin Results in Hypertrophy and Improves Dystrophic Pathology in Mdx Mouse More Than Myostatin Blockade Alone." Skelet Muscle 2018.
चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.